Our study demonstrated that the BCR-free survival, PFS, and CSS were worse in patients with a postoperative GS upgrade to ≥8 than in patients without an upgrade related to the pathologic features and biological behaviors of PCa; and selection of the surgical regimen. The gene discussed is BCR; the disease is posterior cortical atrophy.